Form 4: Accustem Sciences Director and 10% Owner Boosts Stake with Significant Stock Purchases

Gabriele M. Cerrone, a Director and 10% Owner of Accustem Sciences Inc., has increased his indirect beneficial ownership of common stock through two recent purchases totaling 37,196 shares.

Summary

• Gabriele M. Cerrone, identified as both a Director and a 10% Owner of Accustem Sciences Inc. (ACUT), reported two recent transactions involving the purchase of common stock.
• On June 11, 2025, Mr. Cerrone acquired 28,205 shares of Accustem Sciences Inc. common stock at a price of $0.39 per share.
• Subsequently, on June 12, 2025, an additional 8,991 shares of common stock were purchased at a price of $0.83 per share.
• All reported transactions were conducted indirectly through Panetta Partners Limited.
• Following these acquisitions, Mr. Cerrone's total indirect beneficial ownership in Accustem Sciences Inc. common stock stands at 6,500,000 shares.

Sentiment

Score: 8

Explanation: The significant purchases by a key insider, who is both a Director and a 10% owner, indicate strong confidence in the company's future performance and valuation, suggesting a positive outlook.

Positives

• A key insider, Gabriele M. Cerrone, who serves as both a Director and a 10% Owner, increased his stake in Accustem Sciences Inc., signaling strong confidence in the company's current valuation and future prospects.
• The acquisition of 37,196 shares by a significant insider demonstrates a tangible commitment and alignment of interests with other shareholders.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing details an insider transaction, which is specific to the company's ownership structure and does not provide broader industry trends or competitive analysis.

Related Party Transactions

• Gabriele M. Cerrone's beneficial ownership of Accustem Sciences Inc. common stock is held indirectly via Panetta Partners Limited.

Stakeholder Impact

• Shareholders may view the insider purchases as a positive signal, potentially increasing confidence in the company's stock and future performance.

Key Dates

Recommendation

Keywords

Accustem Sciences, ACUT, Form 4, insider trading, beneficial ownership, stock purchase, Gabriele M. Cerrone, Panetta Partners Limited